Antoine Duclos1, Nicolas Voirin. 1. Pôle Information Médicale Evaluation Recherche, Hospices Civils de Lyon, Lyon F-69003, France. antoineduclos@yahoo.fr
Abstract
BACKGROUND: The p-chart is a user-friendly tool for monitoring adverse events. By converting data into knowledge, it is helpful in interpreting and reducing sources of variability in care. Certain basics for developing expertise to use p-charts correctly are necessary. PURPOSE: This paper provides key elements on how to develop and interpret a p-chart for clinical practice, how to successfully integrate this tool within a comprehensive approach, and how to report a study based on p-chart utilization. P-chart building The p-chart combines time series analysis with a graphical presentation of data by plotting successive indicator measurements in chronological order. The pragmatic choice of well-defined indicators to be monitored is essential. Exact control limits based on the binomial distribution and the incorporation of risk adjustment represent important contributions for further improving the tool's performance in health-care settings. P-chart implementation The solution needed to reduce adverse events is not available from measurement alone. The success of routine introduction of the p-chart requires investigation of the causes of indicator variations and the trying out of quality improvement initiatives. It must be supported by strong management leadership within an atmosphere of constructive evaluation. Perspectives The implementation of the p-chart into clinical practice encourages practitioners to continuously undertake a critical examination of the care delivered. Nearly a century after it was created in the manufacturing industry, the control chart now contributes to improving the quality of health-care processes and patient safety.
BACKGROUND: The p-chart is a user-friendly tool for monitoring adverse events. By converting data into knowledge, it is helpful in interpreting and reducing sources of variability in care. Certain basics for developing expertise to use p-charts correctly are necessary. PURPOSE: This paper provides key elements on how to develop and interpret a p-chart for clinical practice, how to successfully integrate this tool within a comprehensive approach, and how to report a study based on p-chart utilization. P-chart building The p-chart combines time series analysis with a graphical presentation of data by plotting successive indicator measurements in chronological order. The pragmatic choice of well-defined indicators to be monitored is essential. Exact control limits based on the binomial distribution and the incorporation of risk adjustment represent important contributions for further improving the tool's performance in health-care settings. P-chart implementation The solution needed to reduce adverse events is not available from measurement alone. The success of routine introduction of the p-chart requires investigation of the causes of indicator variations and the trying out of quality improvement initiatives. It must be supported by strong management leadership within an atmosphere of constructive evaluation. Perspectives The implementation of the p-chart into clinical practice encourages practitioners to continuously undertake a critical examination of the care delivered. Nearly a century after it was created in the manufacturing industry, the control chart now contributes to improving the quality of health-care processes and patient safety.
Authors: Benjamin R Nordstrom; Elizabeth C Saunders; Bethany McLeman; Andrea Meier; Haiyi Xie; Chantal Lambert-Harris; Beth Tanzman; John Brooklyn; Gregory King; Nels Kloster; Clifton Frederick Lord; William Roberts; Mark P McGovern Journal: J Addict Med Date: 2016 Mar-Apr Impact factor: 3.702
Authors: Lidia M V R Moura; Thiago S Carneiro; David Kwasnik; Valdery F Moura; Christine S Blodgett; Joseph Cohen; Mary McKenna Guanci; Daniel B Hoch; John Hsu; Andrew J Cole; M Brandon Westover Journal: Neurol Clin Pract Date: 2017-02
Authors: Mahiben Maruthappu; Matthew J Carty; Stuart R Lipsitz; John Wright; Dennis Orgill; Antoine Duclos Journal: BMJ Open Date: 2014-01-16 Impact factor: 2.692
Authors: Marie-Annick Le Pogam; Catherine Quantin; Oliver Reich; Philippe Tuppin; Anne Fagot-Campagna; Fred Paccaud; Isabelle Peytremann-Bridevaux; Bernard Burnand Journal: JMIR Res Protoc Date: 2017-05-11
Authors: Lucy B Spalluto; Jennifer A Lewis; Sageline LaBaze; Kim L Sandler; Alexis B Paulson; Carol Callaway-Lane; Eric L Grogan; Pierre P Massion; Christianne L Roumie Journal: J Am Coll Radiol Date: 2019-09-06 Impact factor: 5.532